Ulibarrena C - Search Results

1

Frequency and chronology of occurrence of anti-HCV in non-A non-B post-transfusional hepatitis.

Barcena R, Martín-de-Argila C, Ulibarrena C, Erdozain JC, Gil Grande LA, Mateos M. Barcena R, et al. Among authors: ulibarrena c. Rev Esp Enferm Dig. 1993 Oct;84(4):245-8, 241-4. Rev Esp Enferm Dig. 1993. PMID: 8292436 English, Spanish.

2

Prevalence of antibodies to hepatitis C virus after blood transfusion in heart surgery.

Barcena R, Gonzalez A, Martin-de-Argila C, Ulibarrena C, Graus J, Grande LA. Barcena R, et al. Among authors: ulibarrena c. Postgrad Med J. 1994 Aug;70(826):572-5. doi: 10.1136/pgmj.70.826.572. Postgrad Med J. 1994. PMID: 7524052 Free PMC article.

3

[The incidence and chronology of the appearance of anti-HCV in posttransfusional non-A, non-B hepatitis].

Barcena R, Martín-de-Argila C, Ulibarrena C, Erdozain JC, Gil Grande LA, Mateos M. Barcena R, et al. Among authors: ulibarrena c. Rev Esp Enferm Dig. 1993 Oct;84(4):241-4. Rev Esp Enferm Dig. 1993. PMID: 8292435 Spanish. No abstract available.

4

Amylase-producing Bence Jones multiple myeloma with pancreatitis-like symptoms.

Lopez J, Ulibarrena C, Gonzalez-Porque P, Navas G, Roldan E, Cancelas JA, Perez-Oteyza J, Burgaleta C, García-Laraña J, Sastre JL, et al. Lopez J, et al. Among authors: ulibarrena c. Acta Haematol. 1993;90(2):99-101. doi: 10.1159/000204384. Acta Haematol. 1993. PMID: 7506860

5

Red cell lipid abnormalities in acquired acanthocytosis are extended to platelets.

Ulibarrena C, Vecino A, Cesar JM. Ulibarrena C, et al. Br J Haematol. 1994 Jul;87(3):614-6. doi: 10.1111/j.1365-2141.1994.tb08322.x. Br J Haematol. 1994. PMID: 7993804

6

Leg ulcers associated with hydroxyurea therapy.

Sastre JL, Bravo A, Tembrás S, Gómez R, Ulibarrena C. Sastre JL, et al. Among authors: ulibarrena c. Haematologica. 2003 Feb;88(2):EIM01. Haematologica. 2003. PMID: 12604429 No abstract available.

7

Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.

Sastre JL, Ulibarrena C, Bustillo M, Suárez-Gago M, García-Torremocha MS, Vázquez MO. Sastre JL, et al. Among authors: ulibarrena c. Haematologica. 1998 Aug;83(8):763-5. Haematologica. 1998. PMID: 9793271

8

Thalidomide as therapy for intestinal chronic GVHD.

Lopez J, Ulibarrena C, Garcia-Laraña J, Odriozola J, Pérez de Oteyza J, Sastre JL, Navarro JL. Lopez J, et al. Among authors: ulibarrena c. Bone Marrow Transplant. 1993 Mar;11(3):251-2. Bone Marrow Transplant. 1993. PMID: 8467293 No abstract available.

9

[Hypereosinophilic syndrome induced by GM-CSF in a patient with AIDS. Possible response to alpha-interferon treatment].

Sastre JL, Escribano L, Montilla P, Ulibarrena C, Cancelas JA. Sastre JL, et al. Among authors: ulibarrena c. Sangre (Barc). 1994 Oct;39(5):398-9. Sangre (Barc). 1994. PMID: 7754449 Spanish. No abstract available.

10

Low dose cytarabine and Granulocyte / Macrophage-Colony Stimulating Factor induced long-term remission in a patient with acute myeloid leukemia in early relapse after intensive chemotherapy.

Sastre JL, Ulibarrena C, Cantón I, Iglesias M, García-Torremocha S, Vázquez MO. Sastre JL, et al. Among authors: ulibarrena c. Haematologica. 2000;85(E-letters):E09. Haematologica. 2000. PMID: 11114824 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters